Patent Assignment
Reel/Frame 068284/0396
Assignment of Assignor's Interest
Recorded: 2024-08-14
Pages: 11
Assignor
EIGER BIOPHARMACEUTICALS, INC.
Executed: 2024-07-09
Assignee
AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Properties
(5)
Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives
Patent:
10,653,753 →
Application:
16/081,578 →
Publication:
US 2019/0060413
PCT:
PCT/US2017/020596 ↗
Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives
Compositions of Exendin-4 Derivatives
Application:
17/398,551 →
Publication:
US 2021/0369814
Compositions of Exendin-4 Derivatives
Application:
18/471,413 →
Publication:
US 2024/0316156
Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives
Application:
62/303,983 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 13, 2016
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 038900/0454 →
Assignment of Assignor's Interest
Apr 23, 2018
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 045614/0137 →
Assignment of Assignor's Interest
Sep 4, 2018
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 046781/0234 →
Assignment of Assignor's Interest
Apr 17, 2020
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 052433/0164 →
Assignment of Assignor's Interest
Aug 11, 2021
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 057146/0827 →
Security Interest
Jun 10, 2022
From: EIGER BIOPHARMACEUTICALS, INC.; EB PHARMA, LLC; EBPI MERGER, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 060156/0901 →
Assignment of Assignor's Interest
Sep 21, 2023
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 064980/0787 →
Assignment of Assignor's Interest
Sep 24, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068683/0015 →